Skip to main content
OpenTrials

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)

NCT02545842

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 156053 Anshan, China
  • Investigational Site Number 156001 Beijing, China
  • Investigational Site Number 156002 Beijing, China
  • Investigational Site Number 156006 Beijing, China
View all 44 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin

NCT03760991

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational site Argentina Buenos Aires, Argentina
  • investigational site COLOMBIA Colombia
  • investigational site Egypt Egypt
  • investigational site HONG KONG Hong Kong
View all 14 locations
View Trial Details
Completed

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT03767543

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 1240004 Barrie, Canada
  • Investigational Site Number 1240006 Brampton, Canada
  • Investigational Site Number 1240002 Brampton, Canada
  • Investigational Site Number 1240005 Burlington, Canada
View all 32 locations
View Trial Details
Completed

Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy

NCT02855684

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 1560039 Beijing, China
  • Investigational Site Number 1560001 Beijing, China
  • Investigational Site Number 1560017 Beijing, China
  • Investigational Site Number 1560003 Beijing, China
View all 54 locations
View Trial Details
Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

NCT03529123

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 01 Bangalore, India
  • Investigational Site Number 012 Belagavi, India
  • Investigational Site Number 013 Chennai, India
  • Investigational Site Number 017 Coimbatore, India
View all 13 locations
View Trial Details

Related conditions